Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,930Revenue $M111Net Margin (%)-207.9Altman Z-Score12.6
Enterprise Value $M7,930EPS $-2.6Operating Margin %-188.9Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.3Pre-tax Margin (%)-208.5Higher ROA y-yN
Price/Book22.410-y EBITDA Growth Rate %--Quick Ratio6.9Cash flow > EarningsY
Price/Sales60.15-y EBITDA Growth Rate %--Current Ratio7.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-43.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-108.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M108ROIC % (ttm)-1,244.5Gross Margin Increase y-yY

Gurus Latest Trades with ITMN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ITMNMario Gabelli 2014-09-30 Buy 0.02%$40.59 - $73.91
($56.72)
$ 73.8930%New holding60,000
ITMNJoel Greenblatt 2014-09-30 Sold Out $40.59 - $73.91
($56.72)
$ 73.8930%Sold Out0
ITMNJoel Greenblatt 2014-06-30 Buy $26.59 - $47.22
($36.7)
$ 73.89101%New holding6,487
ITMNGeorge Soros 2011-06-30 Sold Out $32.71 - $51.08
($40.18)
$ 73.8984%Sold Out0
ITMNGeorge Soros 2011-03-31 Buy 0.07%$35.09 - $47.13
($39.54)
$ 73.8987%New holding125,000
ITMNGeorge Soros 2010-06-30 Sold Out -0.01%$8.58 - $48.04
($22.74)
$ 73.89225%Sold Out0
ITMNGeorge Soros 2010-03-31 Buy 0.01%$12.95 - $47.25
($21.68)
$ 73.89241%New holding10,705
ITMNBill Gates 2009-06-30 Sold Out -0.02%$10.75 - $17.05
($13.21)
$ 73.89459%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ITMN is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ITMN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Powell Andrew Kenneth WilliamEVP, GC & Secretary 2014-09-02Sell7,500$73.470.57 view
Di Nepi GiacomoEVP Managing Director, Europe 2014-08-15Sell22,085$44.9964.24 view
Nolan Sean P.EVP & CBO 2014-08-13Sell17,000$5047.78 view
ARATA PAUL DEVP, Human Resources & Admin 2014-08-13Sell7,500$5047.78 view
HODGMAN JOHNEVP, Finance & CFO 2014-08-11Sell4,724$43.0571.64 view
WELCH DANIEL GChairman, CEO and President 2014-08-07Sell171,025$44.9864.27 view
ARATA PAUL DEVP, Human Resources & Admin 2014-07-17Sell2,382$4180.22 view
Leff Jonathan AEVP, Research & Development 2014-07-15Sell35,000$43.0871.52 view
Nolan Sean P.EVP & CBO 2014-06-18Sell10,000$47.156.88 view
WELCH DANIEL GChairman, CEO and President 2014-06-16Sell15,000$45.0264.13 view

Quarterly/Annual Reports about ITMN:

    News about ITMN:

    Articles On GuruFocus.com
    Mario Gabelli Comments on InterMune Inc Oct 28 2014 
    Roche to Acquire InterMune and Deliver Hope to Patients Worldwide Aug 25 2014 
    How Sanofi's Growth Strategy Will Catapult Afrezza Into a Blockbuster Drug Aug 20 2014 
    Weekly CEO Sells Highlight: Protective Life Corp, Western Refining Inc, InterMune Inc, and Tableau S Aug 18 2014 
    Weekly Insider Sells Highlight: BX, PCYC, MAS, ITMN Mar 03 2014 
    11 Mar 07 2012 
    WEEKLY CFO SELLS HIGHLIGHT: ITMN, DISCA, WEC, EMAN, WTW, CAH May 22 2011 
    InterMune Inc. (ITMN) Chairman, CEO and President Daniel G Welch sells 44,000 Shares Mar 04 2011 
    InterMune Inc. Reports Operating Results (10-Q) Nov 08 2010 
    InterMune Inc. Reports Operating Results (10-Q) Aug 09 2010 

    More From Other Websites
    After big sale to Roche, InterMune boss jumps to venture capital Jan 08 2015
    Goldman Sachs beats earnings estimates Oct 16 2014
    Roche, Boehringer Drugs Wins Approval for Lung Disease Oct 15 2014
    INTERMUNE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of... Sep 29 2014
    Roche purchases shares in tender offer for InterMune, Inc. Sep 29 2014
    InterMune Reports Memorandum of Understanding in Connection with Consolidated Delaware Action Sep 19 2014
    Roche's $8 billion InterMune buy not a signal for more big deals Sep 16 2014
    [video] Cramer: ACAD and ISIS have room to run Sep 11 2014
    INTERMUNE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Sep 05 2014
    InterMune Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015 Sep 05 2014
    Lifshitz & Miller Law Firm Announces Investigation of China Housing & Land Development, Inc., Cobra... Sep 02 2014
    What You Need to Know About the Roche-InterMune Deal Aug 29 2014
    Cramer: Sector could be hotbed of 'bolt-on' deals Aug 28 2014
    InterMune drug may offer big upside to Roche if aimed at liver Aug 27 2014
    InterMune Stockholders Encouraged to Contact Securities Law Firm about Takeover Aug 27 2014
    INTERMUNE SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the... Aug 27 2014
    INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of InterMune, Inc. and Its Board of... Aug 26 2014
    INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of InterMune, Inc. Over the... Aug 25 2014
    Thorns, Roses, and All Time Highs. Aug 25 2014
    SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest... Aug 25 2014

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK